News | May 03, 2025
SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification
This significant milestone enhances our global regulatory standing
This significant milestone enhances our global regulatory standing
The FDA issued Form 483 with one observation related to building and facility management
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Alembic Pharmaceuticals commissions new facility at Pithampur
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
ekincare has raised a total funding of $22M since 2015 till date
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Subscribe To Our Newsletter & Stay Updated
